Antibody, not Cellular, Immune Responses to SARS-CoV-2 Vaccination Outperform Infection in Inflammatory Bowel Disease Patients

Inflamm Bowel Dis. 2024 May 2;30(5):859-862. doi: 10.1093/ibd/izad265.
No abstract available

Keywords: SARS-CoV-2; biological therapy; immune response; inflammatory bowel disease.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Viral* / blood
  • Antibodies, Viral* / immunology
  • COVID-19 Vaccines* / immunology
  • COVID-19* / immunology
  • COVID-19* / prevention & control
  • Female
  • Humans
  • Immunity, Cellular
  • Inflammatory Bowel Diseases* / immunology
  • Male
  • Middle Aged
  • SARS-CoV-2* / immunology
  • Vaccination

Substances

  • COVID-19 Vaccines
  • Antibodies, Viral